Pricing Log in Create free account

Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) vs Bio-Path Holdings, Inc. (BPTH)

Biodexa Pharmaceuticals PLC Unsponsored ADR and Bio-Path Holdings, Inc. are both Biotechnology companies. Biodexa Pharmaceuticals PLC Unsponsored ADR is the larger, with a market value of $1.3M against $1.1M — 1.2× the size. Bio-Path Holdings, Inc. has the higher net margin (0.00% vs −1,155.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 8 metrics below, Bio-Path Holdings, Inc. leads on 5 and Biodexa Pharmaceuticals PLC Unsponsored ADR on 3.

Valuation

Metric BDRX BPTH Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B n/m n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.20 0.00 0.66
EV/Sales (2.81) n/m 9.02
Earnings yield (102.95%) 0.00% (32.88%)
Free cash flow yield 0.00% 0.00% (23.13%)

Profitability

Metric BDRX BPTH Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin (1,155.70%) 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% 157.01% (51.96%)
Return on assets 0.00% (605.50%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BDRX BPTH Biotechnology median
Revenue growth (TTM) 60.22% — 6.76%
EPS growth (last fiscal year) 89.62% 87.75% 29.88%
Revenue growth, 5-year CAGR (28.78%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BDRX BPTH Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.41 0.07 4.97
Net debt to EBITDA 1.00 0.10 1.01

Dividend

Metric BDRX BPTH Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BDRX BPTH Biotechnology median
Market cap 1.25m 1.07m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack